GSK vs STWD · P/E 13, $103.31B cap vs P/E 18, rev $1.03B
GlaxoSmithKline PLC ADR (GSK) versus Starwood Property Trust Inc (STWD) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Starwood Property Trust Inc (STWD) is a reit - mortgage company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported STWD revenue for 2026-06-30 was $1.03B. Net income was $58.4M. STWD currently screens at market cap $6.48B and trailing P/E 17.9.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. STWD currently screens at market cap $6.48B and trailing P/E 17.9.
Not investment advice. Open the GSK and STWD stock pages for the full models.
Not investment advice.